Financial terms of the deal have not been disclosed.
Phillips-Medisize is a portfolio firm of the US private equity investment company, Golden Gate Capital.
The company provides services to the medical device and diagnostics, drug delivery, primary pharmaceutical packaging, and commercial markets.
Phillips-Medisize offers designing and manufacturing services for products, including drug delivery, mobile and portable medical devices.
It also provides similar services to the primary pharmaceutical packaging and diagnostic products, including disposable insulin pens, glucose meters, inhalation drug delivery devices, single use surgical devices and consumable diagnostic components.
Molex CEO Martin Slark said: “Phillips-Medisize brings strong capabilities to Molex in the medical solutions market globally.
“Combining Molex’s expertise in electronics and our broad manufacturing presence with Phillips-Medisize’s talented and experienced team will help us better serve the growing needs of the global market for innovative connected health solutions.”
Phillips-Medisize president and CEO Matt Jennings said: “Phillips-Medisize and Molex together create a strong alignment for continued growth in the connected health solutions market, while maintaining focus on quality, service and innovation.
“Phillips-Medisize and Molex together create a strong alignment for continued growth in the connected health solutions market, while maintaining focus on quality, service and innovation.”
With operations in around 40 countries, Molex offers electronic solutions and services for multiple markets such as data communications, consumer electronics, industrial, automotive, commercial vehicle and medical.
Image: Molex has acquired Golden Gate Capital’s portfolio firm Phillips-Medisize. Photo: courtesy of Stuart Miles / FreeDigitalPhotos.net.
